Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amy M Scurlock

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 24, 2019
Impact of food allergy on food insecurity and health literacy in a tertiary care pediatric allergy populationMeredith A Dilley, Mallikarjuna Rettiganti, Lynn Christie, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2013
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyBrian P Vickery, Amy M Scurlock, Michael Kulis, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2018
Screening for Wiskott-Aldrich syndrome by flow cytometrySamuel C C Chiang, Sue M Vergamini, Ammar Husami, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH InvestigatorsSayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2025
Introduction of allergenic foods after treatment with omalizumabJennifer Dantzer, Yamini Virkud, Julie Wang, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
The Journal of Allergy and Clinical Immunology|March 1, 2016
Long-term treatment with egg oral immunotherapy enhances sustained unresponsiveness that persists after cessation of therapyStacie M Jones, A Wesley Burks, Corinne Keet, et al.
The Journal of Allergy and Clinical Immunology|October 15, 2021
Allergen-specific T cells and clinical features of food allergy: Lessons from CoFAR immunotherapy cohortsM Cecilia Berin, Charuta Agashe, A Wesley Burks, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|January 24, 2019
Impact of food allergy on food insecurity and health literacy in a tertiary care pediatric allergy populationMeredith A Dilley, Mallikarjuna Rettiganti, Lynn Christie, et al.
The Journal of Allergy and Clinical Immunology|December 8, 2020
Epicutaneous immunotherapy for treatment of peanut allergy: Follow-up from the Consortium for Food Allergy ResearchAmy M Scurlock, A Wesley Burks, Scott H Sicherer, et al.
The Journal of Allergy and Clinical Immunology|December 24, 2013
Sustained unresponsiveness to peanut in subjects who have completed peanut oral immunotherapyBrian P Vickery, Amy M Scurlock, Michael Kulis, et al.
The Journal of Allergy and Clinical Immunology|May 21, 2026
Early life peanut oral immunotherapy associated with long-term ingestion and immunologic changesJennifer A Dantzer, Yamini V Virkud, Amanda L Cox, et al.
The Journal of Allergy and Clinical Immunology|May 6, 2018
Screening for Wiskott-Aldrich syndrome by flow cytometrySamuel C C Chiang, Sue M Vergamini, Ammar Husami, et al.
Lancet (London, England)|January 23, 2022
Efficacy and safety of oral immunotherapy in children aged 1-3 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled studyStacie M Jones, Edwin H Kim, Kari C Nadeau, et al.
The Journal of Allergy and Clinical Immunology. in Practice|February 6, 2026
Management of gastrointestinal symptoms during oral immunotherapy: Guidance from OUtMATCH InvestigatorsSayantani B Sindher, Mirna Chehade, Evan S Dellon, et al.
The Journal of Allergy and Clinical Immunology|May 30, 2025
Introduction of allergenic foods after treatment with omalizumabJennifer Dantzer, Yamini Virkud, Julie Wang, et al.
Pageof 7